No records
|
188 |
Hamid A.R.A.H., Wangge G. |
57202054669;36497482500; |
The importance of evidence based education and policy in public health: Lessons learned from a repeated pandemic |
2021 |
Medical Journal of Indonesia |
30 |
3 |
|
175 |
176 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118807075&doi=10.13181%2fmji.ed.215821&partnerID=40&md5=9f5b4d7b96f6ec8842d115c438f55a1f |
Medical Journal of Indonesia, Universitas Indonesia, Jakarta, Indonesia; Department of Urology, Faculty of Medicine, Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Southeast Asian Ministers of Education-Regional Centre for Food and Nutrition (SEAMEO RECFON)/Pusat Kajian Gizi Regional Universitas Indonesia (PKGR UI), Jakarta, Indonesia |
Hamid, A.R.A.H., Medical Journal of Indonesia, Universitas Indonesia, Jakarta, Indonesia, Department of Urology, Faculty of Medicine, Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Wangge, G., Medical Journal of Indonesia, Universitas Indonesia, Jakarta, Indonesia, Southeast Asian Ministers of Education-Regional Centre for Food and Nutrition (SEAMEO RECFON)/Pusat Kajian Gizi Regional Universitas Indonesia (PKGR UI), Jakarta, Indonesia |
[No abstract available] |
|
coronavirus disease 2019; disease transmission; early diagnosis; Editorial; evidence based medicine; health care policy; human; Indonesia; medical education; medical research; nonhuman; pandemic; polymerase chain reaction; public health; Spanish influenza; vaccination |
Faculty of Medicine, Universitas Indonesia |
08531773 |
|
|
Editorial |
Q4 |
164 |
21905 |
|
|
189 |
Louhenapessy N., Gantini R.S.E., Rahayu S., Lilipory E., Wibowo H., Soedarmono Y., Sutanto I. |
57328098200;57328652300;57189095014;57328098300;57217690943;35729808300;6603791639; |
Evaluating laboratory screening tests for malaria on blood donor candidates to reduce the risk of transfusion-transmitted malaria in an endemic area of indonesia |
2021 |
Medical Journal of Indonesia |
30 |
3 |
|
191 |
197 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118766270&doi=10.13181%2fmji.oa.215491&partnerID=40&md5=56dffb7462c5b89ab6601b6099db844e |
Biomedical Science Institute, Transfusion Science Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Central Blood Transfusion Services, Jakarta, Indonesia; Blood Bank Technology, Indonesian Red Cross, Jakarta, Indonesia; Integrated Laboratory Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Provincial Health Office of Ambon City, Maluku, Indonesia; Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Directorate General of Health Care, Ministry of Health, Jakarta, Indonesia |
Louhenapessy, N., Biomedical Science Institute, Transfusion Science Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Gantini, R.S.E., Biomedical Science Institute, Transfusion Science Program, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Central Blood Transfusion Services, Jakarta, Indonesia, Blood Bank Technology, Indonesian Red Cross, Jakarta, Indonesia; Rahayu, S., Integrated Laboratory Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Lilipory, E., Provincial Health Office of Ambon City, Maluku, Indonesia; Wibowo, H., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Soedarmono, Y., Directorate General of Health Care, Ministry of Health, Jakarta, Indonesia; Sutanto, I., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
BACKGROUND Laboratory screening of blood donors for malaria has not been routinely performed in Indonesia. Current policy and practice simply exclude donors based on a history of active clinical malaria. This study was aimed to evaluate laboratory screening tests for malaria among blood donors in an endemic area of Indonesia. METHODS The study was conducted on 550 consecutive blood samples withdrawn from volunteer donors at the Red Cross Blood Transfusion Unit in Ambon city using microscopic and rapid diagnostic tests for antigen as well as for antibody. Furthermore, 248 of those 550 samples were also tested for the presence of malaria DNA using 18S rRNA marker. Statistical analysis was done descriptively using SPSS software version 15 (SPSS Inc., USA). RESULTS The overall malaria positivity rate among the donors was 4.5% (25/550). None of the specimens tested using microscopy or rapid test for malaria antigen assay were positive. However 22 (4.0%) samples were positive for malaria antibody against Plasmodium falciparum, while 3 (1.2%) were positive by PCR. CONCLUSIONS Laboratory testing for blood donors may be used to prevent transfusion-transmitted malaria in an endemic area of Indonesia. © 2021, Faculty of Medicine, Universitas Indonesia. All rights reserved. |
Blood donors; Indonesia; Malaria |
hemoglobin; immunoglobulin A antibody; immunoglobulin G antibody; immunoglobulin M antibody; RNA 18S; adolescent; adult; Article; blood donor; blood transmission; body weight; endemic disease; female; Giemsa stain; human; Indonesia; laboratory test; major clinical study; malaria; male; microscopy; nonhuman; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; polymerase chain reaction; risk reduction; screening test |
Faculty of Medicine, Universitas Indonesia |
08531773 |
|
|
Article |
Q4 |
164 |
21905 |
|
|
329 |
Ramlan A.A.W., Sugiharto A., Mutakim A. |
57195941841;57226310870;57226313039; |
Accuracy of pediatric advanced life support method for predicting the depth of endotracheal tube in indonesian children |
2021 |
Medical Journal of Indonesia |
30 |
2 |
|
123 |
128 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111164254&doi=10.13181%2fmji.oa.203835&partnerID=40&md5=a6c7bb086d05bdb4faba3e211bf246af |
Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Ramlan, A.A.W., Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Sugiharto, A., Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Mutakim, A., Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
BACKGROUND The pediatric advanced life support (PALS) method can predict the depth of endotracheal tube (ETT) in pediatric patients easily, but it has limitations due to variations in the children’s characteristics, especially the racial consideration. This study compared the accuracy of ETT depth prediction based on the PALS methods in Indonesian children. METHODS Patients aged 0–12 years, who underwent elective surgery with oral intubation, were recruited consecutively based on their ages: 0–24 months and 25 months–12 years for this cross-sectional study in Cipto Mangunkusumo Hospital, Jakarta, Indonesia from June to August 2014. Bland–Altman analysis was used to compare the two measurement methods: PALS method to predict the ETT depth accuracy and auscultation method to confirm the position of the ETT. Furthermore, correlation analysis was done to examine the relationship of age, weight, height, and ETT internal diameter with ETT depth. RESULTS 50 patients were recruited in each group. Bland–Altman test of ETT depth in the 0–24 months age group showed a 1.18 cm mean difference from confirmation using the auscultation method (limits of agreement −0.71 to 3.08). The 25 months–12 years age group showed a 1.11 cm mean difference with limits of agreement were −0.95 to 3.17 from confirmation using the auscultation method. Age and weight had the strongest correlation value to ETT depth in the 25 months–12 years age group (R2 = 62.3%). CONCLUSIONS The PALS method is inaccurate for predicting ETT depth in Indonesian children aged 0–12 years old compared with the auscultation method. © 2021 Authors. |
Endotracheal tube; Pediatrics; Resuscitation |
atracurium besilate; accuracy; age; Article; body height; body weight; child; correlation analysis; cross-sectional study; elective surgery; endotracheal intubation; endotracheal tube internal diameter; female; general anesthesia; human; Indonesian; lung auscultation; major clinical study; male; pediatric advanced life support; physical parameters; racism; school child; tracheostomy |
Faculty of Medicine, Universitas Indonesia |
08531773 |
|
|
Article |
Q4 |
164 |
21905 |
|
|
330 |
Gondhowiardjo S., Hartanto S., Wirawan S., Jayalie V.F., Astiti I.A.P., Panigoro S.S., Sekarutami S.M., Rachman A., Bachtiar A. |
6508327402;57217201121;57226152890;57195939736;57226145786;56790104300;56576294500;15056701600;56683183900; |
Treatment delay of cancer patients in Indonesia: A reflection from a national referral hospital |
2021 |
Medical Journal of Indonesia |
30 |
2 |
|
129 |
137 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110729832&doi=10.13181%2fmji.oa.204296&partnerID=40&md5=0ead2a2c9a147a42c0b4b82c1186bd1e |
Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Administration and Health Policy, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia |
Gondhowiardjo, S., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Hartanto, S., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Wirawan, S., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Jayalie, V.F., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Astiti, I.A.P., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Panigoro, S.S., Department of Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Sekarutami, S.M., Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Rachman, A., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Bachtiar, A., Department of Administration and Health Policy, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia |
BACKGROUND Cancer is a complex disease requiring a multidisciplinary approach in establishing prompt diagnosis and treatment. Treatment in a timely manner is crucial for the outcomes. Hence, this study aimed to provide information on treatment delay including patient and provider delays and its associated factors. METHODS Cancer patients were recruited conveniently in the outpatient clinic of Department of Radiation Oncology, Cipto Mangunkusumo Hospital, Indonesia between May and August 2015. All patients were asked to fill a questionnaire and interviewed in this cross-sectional study. Treatment delay was explored and categorized into patient delay and provider delay. Patient delay could be happened before (patient-delay-1) or after (patient-delay-2) the patient was diagnosed with cancer. Provider delay could be due to physician, system-diagnosis, and system-treatment delays. RESULTS Among 294 patients, 86% patient had treatment delay. Patient delay was observed in 153 patients, and 43% of them had a history of alternative treatment. An older age (p = 0.047), lower educational level (p = 0.047), and history of alternative treatment (p<0.001) were associated with patient delay. Meanwhile, 214 patients had provider delay, and 9%, 36%, and 80% of them experienced physician, system-diagnosis, and system-treatment delays, respectively. All types of provider delay were associated with patient delay (p<0.001). CONCLUSIONS Most of the patient had treatment delay caused by either patient or provider. © 2021 Authors. |
Cancer; Indonesia; Treatment delay |
adolescent; adult; aged; Article; breast cancer; cancer patient; cancer radiotherapy; cross-sectional study; educational status; female; human; Indonesia; major clinical study; male; nasopharynx cancer; outpatient department; patient referral; physiotherapy; prevalence; questionnaire; radiation oncology; risk factor; therapy delay; uterine cervix cancer |
Faculty of Medicine, Universitas Indonesia |
08531773 |
|
|
Article |
Q4 |
164 |
21905 |
|
|
331 |
Irdam G.A., Febriyani, Rasyid N., Taher A. |
57194729795;57226319849;56245069300;7005269743; |
A systematic review of intracavernosal injection of mesenchymal stem cells for diabetic erectile dysfunction |
2021 |
Medical Journal of Indonesia |
30 |
2 |
|
96 |
105 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110674329&doi=10.13181%2fmji.oa.204475&partnerID=40&md5=41f468eff0f07099de19a39da32f2a41 |
Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
Irdam, G.A., Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Febriyani, Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Rasyid, N., Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Taher, A., Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
BACKGROUND As current erectile dysfunction (ED) treatments are limited, other treatment such as stem cells should be explored. Hence, this study aimed to review the sources, method of administration, and therapeutic effect of mesenchymal stem cells (MSCs) for diabetic ED treatment. METHODS All relevant articles regarding the use of MSCs for diabetic ED were searched in PubMed and Google Scholar databases from December 15, 2019 to January 1, 2020 published in the past 10 years. The keywords were “mesenchymal stem cells” and “diabetic ED”. The selection and critical appraisal of the studies were discussed. Diabetic ED was evaluated for functional and structural outcome. Functional outcome in animal studies was assessed by intracavernosal pressure/mean arterial pressure (ICP/ MAP) ratio, meanwhile the structural outcome was done microscopically. In human study, the assessments were done using international index of erectile function score (IIEF-5) to erection hardness score and penile Doppler ultrasonography. RESULTS There were 10 animal studies and 3 human studies. The studies used MSCs from adipose (n = 6), bone marrow (n = 4), placenta (n = 1), umbilical cord (n = 1), and muscle tissue (n = 1). The MSCs were administrated through intracavernosal injection in all studies. In all animal studies, functional outcome was improved, shown in higher ICP/MAP ratio. Microscopically, there were an increase of cavernosal endothelial cells, vascular endothelial growth factor, nitric oxide synthase, and smooth muscle cells. In human studies, IIEF-5 and erection hardness score were improved. Peak systolic velocity was also higher. CONCLUSIONS MSCs may be a promising therapy for diabetic ED; however, long-term safety concerns still need further investigations. © 2021, Faculty of Medicine, Universitas Indonesia. All rights reserved. |
Diabetes mellitus; Erectile dysfunction; Mesenchymal stem cells |
arterial pressure; Article; body mass; bone marrow; data extraction; DNA damage; Doppler ultrasonography; echography; erectile dysfunction; genomic instability; hardness; histochemistry; human; insulin sensitivity; International Index of Erectile Function; intracavernous pressure; mesenchymal stem cell; nonhuman; peak systolic velocity; placenta; questionnaire; shock wave therapy; smooth muscle cell; systematic review; umbilical cord |
Faculty of Medicine, Universitas Indonesia |
08531773 |
|
|
Article |
Q4 |
164 |
21905 |
|
|
345 |
Parikesit D., Witjaksono F., Mochtar C.A., Rasyid N., Hamid A.R.A.H. |
57163830300;57070455800;6506558321;56245069300;57202054669; |
Impact of metabolic syndrome on lower urinary tract symptoms in patients with benign prostate hyperplasia |
2021 |
Medical Journal of Indonesia |
30 |
2 |
|
138 |
142 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110781511&doi=10.13181%2fmji.oa.214256&partnerID=40&md5=1ca9a518c25b6145dc4dc6f550d2833e |
Urology Medical Staff Group, Universitas Indonesia Hospital, Universitas Indonesia, West Java, Depok, Indonesia; Department of Nutrition, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
Parikesit, D., Urology Medical Staff Group, Universitas Indonesia Hospital, Universitas Indonesia, West Java, Depok, Indonesia; Witjaksono, F., Department of Nutrition, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Mochtar, C.A., Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Rasyid, N., Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Hamid, A.R.A.H., Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
BACKGROUND Studies evaluating the relationship between metabolic syndrome (MetS) and lower urinary tract symptoms (LUTS) in men with benign prostate hyperplasia (BPH) are lacking in Indonesia. This study aimed to discover the association of LUTS and MetS in men with BPH. METHODS Subjects who underwent biopsy were recruited from Cipto Mangunkusumo Hospital, Jakarta, Indonesia from January 2014 to January 2018, but only men who had biopsy-proven BPH were included. Body mass index, waist circumference, fasting blood glucose, triglyceride, high-density lipoprotein, prostate volume (PV), and international prostate symptom score (IPSS) were collected before the biopsy. MetS criteria were based on the National Cholesterol Education Program Adult Treatment Panel III. IPSS was assessed for LUTS and consisted of irritative and obstructive symptoms and quality of life (QoL). Independent t-test or Mann–Whitney test was used to analyze numerical data. RESULTS Of 227 men with biopsy-proven BPH, 87 (38.3%) were diagnosed with MetS. PV was similar in men with or without MetS (54.4 [20.3–100] versus 49.9 [19.5–100] cm3, p = 0.239). Men with MetS generally had more LUTS (15 [1–30] versus 11 [0–35], p = 0.005), more irritative symptoms (8 [0–20] versus 6 [0–20], p = 0.007), and lower QoL (4 [0–6] versus 3 [0–6], p = 0.018). CONCLUSIONS BPH patients with MetS had greater LUTS, particularly irritative symptoms and QoL score. @ 2021 Authors. |
Benign prostate hyperplasia; Lower urinary tract symptoms; Metabolic syndrome |
high density lipoprotein cholesterol; triacylglycerol; Article; body mass; cross-sectional study; glucose blood level; human; human tissue; lower urinary tract symptom; major clinical study; male; metabolic syndrome X; prostate hypertrophy; prostate volume; quality of life; questionnaire; waist circumference |
Faculty of Medicine, Universitas Indonesia |
08531773 |
|
|
Article |
Q4 |
164 |
21905 |
|
|
346 |
Irawati Y., Gondhowiardjo T.D., Soebono H. |
57201260313;7801650709;6508242918; |
Efficacy and safety of platinum chain and gold weight implants for paralytic lagophthalmos: A systematic review |
2021 |
Medical Journal of Indonesia |
30 |
2 |
|
106 |
115 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110572321&doi=10.13181%2fmji.oa.214683&partnerID=40&md5=1e4455ed4f7b0f8707adf603031b37e0 |
Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; JEC Eye Hospitals and Clinics, Jakarta, Indonesia; Department of Dermatovenereology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito Central General Hospital, Yogyakarta, Indonesia |
Irawati, Y., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, JEC Eye Hospitals and Clinics, Jakarta, Indonesia; Gondhowiardjo, T.D., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, JEC Eye Hospitals and Clinics, Jakarta, Indonesia; Soebono, H., Department of Dermatovenereology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Dr. Sardjito Central General Hospital, Yogyakarta, Indonesia |
BACKGROUND Surgery has been proposed as a treatment of paralytic lagophthalmos. However, no consensus has been reached on the best treatment. This study was aimed to investigate the efficacy and safety between platinum chain and gold weight implants to treat paralytic lagophthalmos. METHODS This study used all randomized controlled trials or observational studies (prospective or retrospective) using platinum chain and gold weight implants for paralytic lagophthalmos surgery that were published from 1990 to 2020 in the PubMed, Cochrane, and Google Scholar databases. Efficacy was indicated by the reduction of ≥3 in lagophthalmos, and safety was measured based on complications after surgery. RESULTS The efficacy of platinum chain and gold weight implants were 60–100% and 10–93.6%, respectively. The complications of platinum chain implant were 0–2.9% of extrusion and 0–3.3% of migration. However, gold weight implant had 0–13.3% of migration. CONCLUSIONS Both platinum chain and gold weight implants have similar efficacy to treat paralytic lagophthalmos. However, gold weight implant has a higher rate of complication. © 2021 Authors. |
Paralytic lagophthalmus; Prostheses and implants; Surgical techniques |
acoustic neuroma; Article; drug efficacy; drug safety; human; lagophthalmos; lid loading technique; paralytic lagophthalmos; systematic review; visual acuity |
Faculty of Medicine, Universitas Indonesia |
08531773 |
|
|
Article |
Q4 |
164 |
21905 |
|
|
377 |
Dharma S., Dakota I., Firdaus I., Danny S.S., Zamroni D., Yudha A., Susanto A., Siswanto B.B. |
55101301700;55796663700;55796864700;56221848700;57215684617;57223107725;57225841633;14422648800; |
Performance of Primary Angioplasty for STEMI during the COVID-19 Outbreak |
2021 |
International Journal of Angiology |
30 |
2 |
210001 |
148 |
154 |
|
1 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104870014&doi=10.1055%2fs-0041-1727133&partnerID=40&md5=5b349c0b1a14cb4af4bcc5b822d2e435 |
Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jl S Parman Kav 87, Slipi, Jakarta Barat, Jakarta, 11420, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Catheterization Laboratory Nurse Manager, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia |
Dharma, S., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jl S Parman Kav 87, Slipi, Jakarta Barat, Jakarta, 11420, Indonesia; Dakota, I., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Firdaus, I., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Danny, S.S., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Zamroni, D., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Yudha, A., Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Susanto, A., Catheterization Laboratory Nurse Manager, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Siswanto, B.B., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia |
There has been concern whether the declining cases of ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) outbreak associate with primary angioplasty performance. We assessed the performance of primary angioplasty in a tertiary care hospital in Jakarta, Indonesia, by comparing the door-to-device (DTD) time and thrombolysis in myocardial infarction (TIMI) flow after angioplasty between two periods of admission: during the outbreak of COVID-19 (March 1 to May 31, 2020) and before the outbreak (March 1, to May 31, 2019). Overall, there was a relative reduction of 44% for STEMI admission during the outbreak (n = 116) compared with before the outbreak (N = 208). Compared with before the outbreak period (n = 141), STEMI patients who admitted during the outbreak and received primary angioplasty (n = 70) had similar median symptom onset-to-angioplasty center admission (360 minutes for each group), similar to radial access uptake (90 vs. 89.4%, p = 0.88) and left anterior descending infarct-related artery (54.3 vs. 58.9%, p = 0.52). The median DTD time and total ischemia time were longer (104 vs. 81 minutes, p < 0.001, and 475.5 vs. 449 minutes, p = 0.43, respectively). However, the final achievement of TIMI 3 flow was similar (87.1 vs. 87.2%), and so was the in-hospital mortality (5.7 vs. 7.8%). During the COVID-19 outbreak, we found a longer DTD time for primary angioplasty, but the achievement of final TIMI 3 flow and in-hospital mortality were similar as compared with before the outbreak. Thus, primary angioplasty should remain the standard of care for STEMI during the COVID-19 outbreak. © 2020. International College of Angiology. All rights reserved. |
COVID-19 outbreak; performance measures; primary angioplasty |
acetylsalicylic acid; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; clopidogrel; creatinine; dipeptidyl carboxypeptidase inhibitor; heparin; salicylic acid; simvastatin; ticagrelor; adult; angioplasty; Article; cardiovascular risk factor; catheterization; controlled study; coronary angiography; coronavirus disease 2019; creatinine blood level; door to device time; emergency ward; epidemic; female; fibrinolytic therapy; health care utilization; heart left bundle branch block; hospital admission; hospital discharge; human; in-hospital mortality; Indonesia; information processing; ischemia time; length of stay; major clinical study; male; non ST segment elevation myocardial infarction; observational study; outcome assessment; percutaneous coronary intervention; pos |
Thieme Medical Publishers, Inc. |
10611711 |
|
|
Article |
Q3 |
293 |
15070 |
|
|
385 |
Silalahi T., Alwi I., Suyatna F., Sartika K.D. |
56275255400;15055173800;57303311300;57221849323; |
Curcumin's Effect on Inflammatory Response following Percutaneous Coronary Intervention in Adult Patients with Stable Coronary Heart Disease |
2021 |
International Journal of Angiology |
30 |
2 |
200063 |
132 |
138 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100412387&doi=10.1055%2fs-0040-1720969&partnerID=40&md5=d55e2b0c365eafd1a179c7602474794d |
Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine Krida Wacana Christian University, Cipto Mangunkusumo National General Hospital, Arjuna Utara Street No. 6, Duri Kepa, Kebon Jeruk, Jakarta, 11510, Indonesia; Division Cardiovascular, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Department of Clinical Pharmacology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
Silalahi, T., Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine Krida Wacana Christian University, Cipto Mangunkusumo National General Hospital, Arjuna Utara Street No. 6, Duri Kepa, Kebon Jeruk, Jakarta, 11510, Indonesia; Alwi, I., Division Cardiovascular, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Suyatna, F., Department of Clinical Pharmacology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Sartika, K.D., Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine Krida Wacana Christian University, Cipto Mangunkusumo National General Hospital, Arjuna Utara Street No. 6, Duri Kepa, Kebon Jeruk, Jakarta, 11510, Indonesia |
Cardiovascular diseases play major roles in the health problems worldwide especially in Indonesia. Percutaneous coronary intervention (PCI) is a minimally invasive procedure with relatively low complications. However, high inflammatory response post-PCI has showed adverse events even after administration of standard medication. Previous studies showed that curcumin was able to reduce inflammatory response in adult patients with stable coronary heart disease (CHD). This article determines the efficacy of oral administration of curcumin in reducing inflammatory response post-PCI with stable CHD. A double-blind randomized controlled trial on 50 adult patients comparing curcumin and placebo was performed in Cipto Mangunkusumo General Hospital and Jakarta Heart Center within April and June 2015. Either curcumin (45 mg/day) or placebo was given 7 days prior to PCI until 2 days after PCI. Inflammatory markers (high-sensitivity C-reactive protein [hsCRP] and soluble CD40 ligand [sCD40L]) were measured in three phases (7 days prior PCI, 24 hours post-PCI, and 48 hours post-PCI). There were no significant differences in the reduction of hsCRP and sCD40L between curcumin and placebo groups in three phases of measurement. Curcumin significantly reduce the serum hsCRP (p = 0.006) and sCD40L (p = 0.002) 7 days before PCI to 48 hours post-PCI. The decrement of hsCRP (-14.2% vs. -7.4%) and sCD40L (-24.3% vs. -13.2%) from 24 to 48 hours post-PCI was higher in the curcumin group than placebo group. The administration of curcumin 45 mg dose daily for 7 days prior PCI until 48 hours post-PCI is useful in reducing inflammatory response post-PCI with stable CHD. © 2020. International College of Angiology. All rights reserved. |
curcumin; inflammatory response; PCI; stable CHD |
acetylsalicylic acid; C reactive protein; CD40 ligand; clopidogrel; curcumin; placebo; adult; Article; clinical article; controlled study; dose response; double blind procedure; drug efficacy; female; human; human tissue; inflammatory disease; ischemic heart disease; male; measurement; middle aged; percutaneous coronary intervention; priority journal; protein blood level; randomized controlled trial; treatment response |
Thieme Medical Publishers, Inc. |
10611711 |
|
|
Article |
Q3 |
293 |
15070 |
|
|
484 |
Sumantri S., Rengganis I., Laksmi P.W., Hidayat R., Koesnoe S., Shatri H. |
6504606748;8449988000;8448343700;37067327300;26028015000;28767986500; |
The impact of low muscle function on health-related quality of life in Indonesian women with systemic lupus erythematosus |
2021 |
Lupus |
30 |
4 |
|
680 |
686 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099752699&doi=10.1177%2f0961203320988595&partnerID=40&md5=98c96d7b7268512fcf94e7eabca204b8 |
Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Department of Internal Medicine, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Geriatric Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Psychosomatic Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia |
Sumantri, S., Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia, Department of Internal Medicine, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Rengganis, I., Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Laksmi, P.W., Geriatric Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Hidayat, R., Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Koesnoe, S., Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia; Shatri, H., Psychosomatic Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Depok, Indonesia |
Objective: There was no study aimed at evaluating the effect of muscle function on SLE patients' quality of life using the Sarcopenia Quality of Life (SarQoL) questionnaire. Methods: This cross-sectional study recruited 61 women with SLE consecutively, muscle function was measured with Jamar handheld-dynamometer and 6-meter walk test, HRQoL was measured with Sarcopenia Quality of Life (SarQoL) questionnaire. The cut-off point for low muscle strength (<18 kg) and low gait speed (<1.0 m/s) was according to the Asian Working Group on Sarcopenia 2019 criteria. Statistical analysis was conducted with a t-test for mean difference, and linear regression was used to adjust confounders (age, protein intake, physical exercise, and disease activity). Results: The subjects' mean muscle strength was 19.54 kg (6.94), and 44.3% (n = 27) was found to have low muscle strength. The subjects' mean gait speed was 0.77 m/s (0.20), and 90.3% (n = 55) was found to have low gait speed. The difference of total SarQoL score in subjects with normal and low muscle strength was found to be significant; 74.86 (9.48) vs. 65.49 (15.51) (p = 0.009), and still statistically significant after adjustments with age, protein intake, physical exercise level, and disease activity [B 0.56; 95% CI 0.08–1.03; p = 0.022]. The difference of total SarQoL score in subjects with normal and low physical performance was found to be not significant, 70.67 (11.08) vs. 70.72 (13.56) (p = 0.993). Conclusion: There was a significant difference in SarQoL's total score in normal compared with low muscle strength groups of Indonesian women with SLE. © The Author(s) 2021. |
health-related quality of life; Muscle function; muscle strength; physical performance; SarQoL; systemic lupus erythematosus |
corticosteroid; creatine kinase; prednisone; vitamin D; protein; adult; age; Article; corticosteroid therapy; creatine kinase blood level; cross-sectional study; disease activity; exercise; female; human; Indonesian; kidney function; low drug dose; lupus erythematosus nephritis; major clinical study; muscle function; muscle mass; muscle strength; pain severity; physical activity; physical performance; priority journal; protein intake; quality of life; quality of life assessment; Sarcopenia Quality of Life Questionnaire; six minute walk test; SLEDAI; systemic lupus erythematosus; vitamin blood level; walking speed; comparative study; epidemiology; immunology; Indonesia; muscle; pathophysiology; physiology; procedures; psychology; quality of life; questionnaire; sarcopenia; severity of illne |
SAGE Publications Ltd |
09612033 |
|
33470149 |
Article |
Q2 |
1069 |
3961 |
|
|